Investing Profile

Klaus Veitinger

InvestorVC
Venture Partner at Orbimed
orbimed.comNew York, New York
Photo of Klaus Veitinger, Venture Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
7
$18B
CompanyStageDateRound SizeTotal Raised
Sparrow Pharmaceuticals
Series UnknownApr 2024$10M
Series AMay 2021$50M
$60M
Alpheus Medical
Series ANov 2022$14M
Series ANov 2021$16M
$30M
Co-investors: Daniel Coley (Cofounders Capital), Imran Eba (Action Potential Venture Capital)
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: Aaron Royston (venBio), David Allison (Westlake Village BioPartners)
Promentis Pharmaceuticals
Series CMar 2017$26M
$26M